Search results for "OTHER"

showing 10 items of 12132 documents

Imaging-Based Preoperative Planning

2017

Liver resection in the treatment of colorectal liver metastases, as for any other primary or secondary liver tumor, needs to be oncologically effective and surgically safe. Both goals need equal consideration, and imaging-based preoperative planning is paramount for achieving each of them. Preoperative imaging should ideally identify all metastatic lesions in the liver, as well as extrahepatic disease. Furthermore, it should provide an anatomical roadmap with the exact localization of each lesion within the segmental hepatic anatomy, and its proximity to adjacent vasculo-biliary structures, to allow for proper resection leaving the patient with a sufficiently functioning liver remnant. This…

medicine.medical_specialtyChemotherapyLiver tumorMetastatic lesionsPreoperative planningmedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentmedicine.diseaseResectionLesionmedicineRadiologymedicine.symptombusinessLiver function testsPreoperative imaging
researchProduct

Combination Treatment with Imatinib and Mitoxantrone/Etoposide Is a Suitable Preparative Regimen before Allogeneic Transplantation in Patients with M…

2005

Abstract In advanced BCR-ABL-positive leukemia, combination of chemotherapy with imatinib is expected to result in better reduction of leukemia cell load and may delay or offset clonal selection of resistant leukemia cells, thus improving the survival. We carried out a prospective phase I/II combination trial for patients (pts) with myeloid blast crisis of chronic myelogenous leukemia (CML). Pts were treated with imatinib+mitoxantrone/etoposide in four cohorts starting from mitoxantrone 10mg/m2/d and etoposide 100 mg/m2/d for 2 or 3 consecutive days and start of imatinib 600mg/d from day 15 (coh. 1 and 2) or from day 1 (coh. 3 and 4, respectively). After hematologic reconstitution following…

medicine.medical_specialtyChemotherapyMitoxantronebusiness.industrymedicine.medical_treatmentImmunologyMyeloid leukemiaCell BiologyHematologymedicine.diseaseBiochemistryGastroenterologyTransplantationImatinib mesylateInternal medicineCytarabineMedicinebusinessEtoposidemedicine.drugChronic myelogenous leukemiaBlood
researchProduct

Prevention and treatment of oral mucositis in patients receiving chemotherapy

2013

Oral mucositis is one of the most common side effects of cancer treatment (chemotherapy and/or radiotherapy). It is an inflammatory process that affects the mucosa of the oral cavity, giving rise to erythematous areas in combination with ulcers that can reach a large size. The true importance of oral mucositis is the complications it causes – fundamentally intense pain associated to the oral ulcers, and the risk of overinfection. This in turn may require reduction or even suspension of the antineoplastic treatment, with the risk of seriously worsening the patient prognosis. This points to the importance of establishing therapeutic tools of use in the prevention and/or treatment of mucositis…

medicine.medical_specialtyChemotherapyOral Medicine and Pathologybusiness.industrymedicine.medical_treatmentReviewOral cavitymedicine.diseaseDermatologyCancer treatmentRadiation therapymedicineMucositisIn patientOral ulcersbusinessGeneral DentistryLarge sizeJournal of Clinical and Experimental Dentistry
researchProduct

Effectiveness of Enteric-Coated Preparations on Nutritional Parameters in Cystic Fibrosis

1988

To evaluate the effectiveness of enteric-coated pancreatic enzyme supplements in comparison to conventional preparations of ingested enzyme on growth and nutritional parameters of patients with cystic fibrosis, we conducted a long-term study involving 40 patients. The data reproduced here were recorded after 6 months of therapy with powder-containing capsules or with enteric-coated products. Fat absorption was estimated by measurement of steatorrhoea with the steatocrit method. All parameters studied improved after enteric-coated pancreatic enzyme therapy, with a statistically significant increase in weight, cholesterol and haemoglobin values. Furthermore, the number of patients with positi…

medicine.medical_specialtyChemotherapyPancreatic diseaseCholesterolbusiness.industrymedicine.medical_treatmentRespiratory diseaseGastroenterologymedicine.diseaseGastroenterologyEnteric coatingCystic fibrosischemistry.chemical_compoundEndocrinologymedicine.anatomical_structurechemistryOral administrationInternal medicinemedicinebusinessPancreasmedicine.drugDigestion
researchProduct

Intraarterielle präoperative Chemotherapie fortgeschrittener Zervixkarzinome

1991

Three patients suffering from very advanced primary cancers of the cervix uteri (FIGO II B or III B) were treated. By preoperative selective perfusion of both uterine arteries, using cis-platinum alone, a distinct reduction of the tumour volume was achieved. This was demonstrated clinically and also by CAT scan and NMR technique. The elevated serum CEA and SCC levels decreased to normal values. The histomorphology of the Wertheim-Meigs specimens revealed no tumour invasion of the initially infiltrated parametria. This treatment modality has been developed to minimise the toxic side effects of the inductive (neo-adjuvant) chemotherapy for cervical cancers.

medicine.medical_specialtyChemotherapyPathologybusiness.industrymedicine.medical_treatmentObstetrics and GynecologyCancerNormal valuesmedicine.diseaseElevated serummedicine.anatomical_structureMaternity and MidwiferymedicineIntra arterialPreoperative chemotherapyRadiologybusinessPerfusionCervixGeburtshilfe und Frauenheilkunde
researchProduct

Primary paraesophageal Ewing’s sarcoma: an uncommon case report and literature review

2015

Ewing’s sarcoma is a rare and highly aggressive cancer most frequently arising in people under 20 years of age. We report an uncommon case of primary paraesophageal Ewing’s sarcoma in a 25-year-old male harboring the infrequent EWSR1/ERG fusion transcript with multiple splice variants coexisting in the same tumor. The patient was totally refractory to chemotherapy and died 17 months after diagnosis. We underscore the need for better understanding of the molecular pathogenesis of the disease and improved systemic therapy options.

medicine.medical_specialtyChemotherapyPathologyrecurrenceParaesophagealbusiness.industrymedicine.medical_treatmentMolecular pathogenesisEwing's sarcomaCase ReportDiseasemedicine.diseaseDermatologySystemic therapyOncologyFusion transcriptimmunohistochemistryMedicinePharmacology (medical)SarcomaEwing’s sarcomabusinessfusion genesOncoTargets and Therapy
researchProduct

Tumor Oxygenation Under Normobaric and Hyperbaric Hyperoxia

1997

Tumor hypoxia is an important factor limiting the efficiency of sparsely ionizing ra-diation and O2-dependent chemotherapy. Since the tumor pO2 is the result of a dynamic steady state between oxygen supply and O2 consumption of the tumor tissue, hypoxia could be reduced either by increasing the O2-supply or by reducing the O2 demand of the tumor cells. The O2 supply can be improved for instance by (i) increasing the arterial oxy-gen partial pressure, (ii) improving (and homogenizing) the tumor perfusion, or (iii) en-hancing the O2 release from blood into the tissue by right-shifting the HbO2 dissociation curve. Theoretically, it should also be possible to improve tumor oxygenation by a rela…

medicine.medical_specialtyChemotherapyTumor hypoxiabusiness.industryHyperbaric oxygenationmedicine.medical_treatmentOxygen–haemoglobin dissociation curveTumor OxygenationHyperbaric hyperoxiaInternal medicineTumor perfusionCardiologyMedicineRadiosensitivitybusiness
researchProduct

Multiple pulmonary and multivesicular interatrial septum hydatid cysts in a native italian patient

2008

Multivesicular, pulmonary and cardiac hydatidosis are rarely observed and can give rise to serious complications. Cysts can remain asymptomatic for a long time, until they reveal themselves perforating into cardiac chambers and/or pulmonary arteries or the systemic circulation. A rare case of multivesicular interatrial septum hydatid cyst with multiple pulmonary involvement in a native Italian farm labourer is reported. Clinical, radiological, serological and histological findings are described. MR imaging showed the exact anatomic location and the multivesicular nature of the cardiac cyst and was useful in planning surgical treatment. A successful outcome was achieved with a combination of…

medicine.medical_specialtyChemotherapybiologySettore MED/17 - Malattie Infettivebusiness.industrymedicine.medical_treatmentbiology.organism_classificationmedicine.diseaseSystemic circulationAsymptomaticSurgeryAlbendazoleInfectious Diseasesmedicine.anatomical_structuremedicineCystEchinococcus granulosus cardiac hydatidosis multivesicular hydatic cyst pulmonary hydatidosismedicine.symptomEchinococcus granulosusbusinessmedicine.drugInteratrial septumRare disease
researchProduct

Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiency

2003

Summary objective Little is known of the usefulness of GH secretagogues (GHSs) in GH-deficient (GHD) adults. The objective of this study was to determine the number of responders to treatment with NN703 in GHD adults. design A multicentre, randomized, double-blind, and placebo-controlled study. patients Ninety-seven GHD adults were included. measurements The GH response before and after 1 week of oral treatment with NN703 (n = 83) or placebo (n = 14) was determined. The first and last dose of NN703 was 3 mg/kg, whereas the dose of NN703 was 1·5 mg/kg/day during the 6 days between the first and last doses. Furthermore, all 97 patients received 1 µg/kg GH-releasing hormone (GHRH) 3 weeks afte…

medicine.medical_specialtyChemotherapybusiness.industryEndocrinology Diabetes and Metabolismmedicine.medical_treatmentPlacebomedicine.diseaseGrowth hormone deficiencyEndocrinologyBlood pressureEndocrinologyOral administrationGrowth hormone secretagogueInternal medicineStatistical significancemedicinebusinessHormoneClinical Endocrinology
researchProduct

Prognostic factors in the treatment of Ewing's sarcoma

1987

From 1981 up to February 1985, a total of 93 protocol patients entered the study CESS 81. The protocol recommended an initial 18-week period of polychemotherapy (VACA) followed by local therapy and two additional cycles of chemotherapy. Local therapy consisted either of radical surgery or of incomplete resection plus postoperative irradiation with 36 Gy or of radiotherapy alone (46 and 60 Gy). Centrally located lesions were always irradiated with 60 Gy. This article summarizes the data after 5 years. Data of 93 patients were analysed in October 1986 after a median follow-up of 37 months. The projected 5-year survival is 50%. The relapse rate was 42%, distant relapses occurred in 19%, local …

medicine.medical_specialtyChemotherapybusiness.industryPaediatric oncologymedicine.medical_treatmentPostoperative irradiationEwing's sarcomaHematologymedicine.diseaseSurgeryRadiation therapyOncologyMedicineCombined Modality TherapyRadiology Nuclear Medicine and imagingSarcomaRadical surgerybusinessRadiotherapy and Oncology
researchProduct